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Abstract
Background: Matrix metalloproteinase (MMP) is involved in the upper airway remodeling process. We hypothesized 
that genetic variants of the MMP-9 gene are associated with cases of chronic rhinosinusitis with nasal polyposis.
Methods: We conducted a case-control study where 203 cases of chronic rhinosinusitis with nasal polyposis and 730 
controls were enrolled. Three tagging single nucleotide polymorphisms (SNPs) and one promoter functional SNP 
rs3918242 were selected. Hardy-Weinberg equilibrium (HWE) was tested for each SNP, and genetic effects were 
evaluated according to three inheritance modes. Haplotype analysis was also performed. Permutation was used to 
adjust for multiple testing.
Results: All four SNPs were in HWE. The T allele of promoter SNP rs3918242 was associated with chronic rhinosinusitis 
with nasal polyposis under the dominant (nominal p = 0.023, empirical p = 0.022, OR = 1.62) and additive models 
(nominal p= 0.012, empirical p = 0.011, OR = 1.60). The A allele of rs2274756 has a nominal p value of 0.034 under the 
dominant model and 0.020 under the additive model. Haplotype analysis including the four SNPs showed a global p 
value of 0.015 and the most significant haplotype had a p value of 0.0045. We did not see any SNP that was more 
significant in the recurrent cases.
Conclusions: We concluded that MMP-9 gene polymorphisms may influence susceptibility to the development of 
chronic rhinosinusitis with nasal polyposis in Chinese population.
Background
Tissue remodeling has gained increasing interest in the
pathogenesis of chronic upper and lower airway disease.
It is a dynamic process that involves extracellular matrix
(ECM) production and degradation leading to either a
normal reconstruction process or a pathological struc-
ture [1]. Nasal polyposis is a chronic inflammatory dis-
ease in the upper airway. The histological appearance of
nasal polyposis is characterized by inflammatory cell
infiltration, modifications of epithelial cell differentiation,
and tissue remodeling that includes basement membrane
thickening, gland modifications, ECM accumulation and
edema. Previous studies suggested that polyposis forma-
tion involved ECM protrusion through an initial localized
epithelial defect [2]. Interactions between epithelial,
stromal, and inflammatory cells could then perpetuate
further polyposis growth. Although inflammatory cells,
especially eosinophils, are thought to play an important
role in nasal polyposis, the sequence of events for the
development of polyposis is still controversial.
Matrix metalloproteinases (MMPs) are a family of zinc
and calcium-dependent endopeptidases that are known
to be important to remodel the ECM. MMP-9 (92 kD
type IV Collagenase, gelatinase B) cleaves type IV colla-
gen which is the major structural component of basement
membrane. Studies also suggested that MMP-9 may play
a  c r u c i a l  r o l e  i n  a i r w a y  r e m o d e l i n g  i n  a s t h m a  [ 3 ] .  I n
transgenic animal studies, an elevated level of MMP-9
was associated with defects in bronchial architecture [4].
Upregulation of MMP-9 in the nasal polyposis may dam-
age the collagen of basement membrane of epithelia and
blood vessels, causing increases in permeability and
edema in the stroma. Elevated levels of MMP-9 protein
[5-8] and MMP-9 mRNA [6,7] were found in the cases of
nasal polyposis. Elevated plasma MMP-9 level was also
reported recently in patients with allergic nasal polyps
[9]. Patients with poor-healing reaction after sinus sur-
gery had more severe edematous and fibrotic changes
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[10], and higher amounts of MMP-9 in both nasal secre-
tions [11] and connective tissue [12] when compared with
good healers. Therefore MMP-9 may play a role in the
pathogenesis or recurrence of the nasal polyposis. To our
knowledge, there is no published data regarding the rela-
tionship between MMP-9  genetic polymorphisms and
the risk of the chronic rhinosinusitis with nasal polyposis.
We conducted a case-control study to systematically
investigate the role of MMP-9 tagging single nucleotide
polymorphisms (tSNPs) and a promoter functional poly-
morphism in the development of chronic rhinosinusitis
with nasal polyposis in a Chinese population residing in
Taiwan.
Methods
Subjects
We recruited 203 patients of bilateral chronic rhinosinus-
itis with nasal polyposis at the Kaohsiung Medical Uni-
versity Hospital between October 2005 and June 2007.
The diagnosis of chronic rhinosinusitis with nasal poly-
posis was based on history, physical examination, nasal
endoscope, and sinus CT scan. Patients with malignan-
c i e s  o r  a s t h m a  w e r e  e x c l u d e d  f r o m  t h e  s t u d y .  A l l  t h e
patients were followed up at least three months after sur-
gery. Recurrence was defined as a patient with newly
developed pedunculated nasal polyps (instead of cobble-
stone or polypoid mucosa) fully occupying the middle
meatus three months after surgery using either anterior
rhinoscope or nasal endoscope. Recurrence was identi-
fied in twenty six patients for whom revision surgery was
performed at our institution. A total of 730 control sub-
jects were used in the present study and they were
recruited from the general populations who volunteered
to participate in our study while receiving a health
screening examination at our Hospital. None of the con-
trols reported major disable diseases upon enrollment.
Information on demographic characteristics was col-
lected. The study was proved by the Institutional Review
Board (IRB) of Kaohsiung Medical University Hospital
and written informed consent was given by each subject.
SNP selection and Genotyping
Genomic DNA was extracted from peripheral blood by a
standard method. Three tSNPs were selected from the
HapMap Project (International HapMap Consortium)
and all of them have the minor allele frequency ≥ 10% in
the Han Chinese population. The three tSNPs are: the
non-synonymous SNP rs2664538 (Gln/Arg) at exon 6
(this SNP was merged to rs17576), intronic SNP
rs3787268 at intron 8 and non-synonymous SNP
rs2274756 (Gln/Arg) at exon 12 (this SNP was merged to
rs17577). In addition, we also chose one commonly stud-
ied promoter functional SNP (rs3918242, i.e. -1562 C/T).
Genotyping for the three tSNPs was carried out by using
the TaqMan 5' nuclease assay (Applied Biosystems, Foster
City, USA). Briefly, PCR primers and TaqMan Minor
Groove Binder (MGB) probes were designed and reac-
tions were performed in 96-well microplates with ABI
9700 thermal cyclers (Applied Biosystems, Foster City,
USA). Fluorescence was measured with an ABI 7500 Real
Time PCR System (Applied Biosystems, Foster City, USA)
and analyzed with its System SDS software version 1.2.3.
Genotyping for promoter SNP rs3918242 (-1562C/T) was
determined by the polymerase chain reaction (PCR)-
restriction fragment length polymorphism (RFLP)
method. The forward and reverse primers were 5' GCCT-
GGCACATAGTAGGCCC 3' and 5' CTTCCTAGCCA-
GCCGGCATC 3', respectively [13]. The restriction site
was detected by SphI [13].
Statistical analysis
Continuous variables were analyzed by independent t test
and were presented as mean ± SD. The allele frequency
was obtained by direct gene counting. Hardy-W einberg
equilibrium (HWE) was checked in controls by using the
x2  test. Multiple logistic regression analysis was per-
formed to assess the genetic effect with adjustment for
age and sex. We examined the effect of the minor allele of
each SNP in three genetic models (dominant, additive,
and recessive). We also performed a subset analysis by
stratifying the cases according to recurrence of the dis-
ease. SPSS 13.0 version for Windows (Chicago, IL, USA)
was used for statistical analysis. Linkage disequilibrium
(LD) was assessed for any pair of SNPs and haplotype
blocks were defined using the default setting of the Hap-
loview software [14]. We used the Hap-Clustering pro-
gram [15] to evaluate haplotype-phenotype association.
To adjust for multiple testing, we also presented empiri-
cal p values by 10,000 permutations.
Results
Study Participants
Table 1 shows the baseline characteristics of the subjects.
The mean age (years) was 43.8 ± 16.5 in cases and 54.4 ±
11.9 in controls. The sex distribution in cases was 2.1:1
(male to female) which is similar to the ratio reported
previously [16,17], and was 1:1.4 in controls. Sixty-four
patients (31.5%) had recurrent nasal polyps.
Single SNP Results
The distribution of MMP-9  genotypes was in HWE
among controls (all p values > 0.05) for all SNPs. The
g e n o t y p i n g  c a l l  r a t e s  r a n g e d  f r o m  9 2 %  t o  9 8 % .  I n  t h e
analysis of overall data (Table 2), the multivariate logistic
regression model showed that the T allele of promoter
SNP rs3918242 was associated with chronic rhinosinus-
itis with nasal polyposis under the dominant (nominal p
= 0.023, empirical p = 0.022, OR = 1.62) and additiveWang et al. BMC Medical Genetics 2010, 11:85
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Table 1: Baseline demographics of study characteristics
Characteristic Cases (n = 203) Control (n = 730)
Age, mean (SD) 43.8 (16.5) 54.4 (11.9)
Sex (male to female ratio) 137/66 (2.1:1) 299/420 (1:1.4)
Smoker 39 (19.2%) 130 (17.8%)
Nasal polyposis recurrence, No.(%)
Yes 64 (31.5%)
No 139 (68.5%)
Table 2: Four SNPs and their relationships with nasal polyposis under three genetic models
SNP disease status Genotype (n)(%) p
Dominant Additive Recessive
rs3918242 case TT(6)(3%) CT(44)(21.7%) CC(137)(67.5%) 0.023* 0.012* 0.097
(promoter) control TT(4)(0.5%) CT(125)(17.1%) CC(560)(76.7%)
rs2664538 case AA(16)(7.9%) AG(57)(28.1%) GG(119)(58.6%) 0.640 0.752 0.073
(in exon 6) control AA(37)(4.7%) AG(246)(33.7%) GG(428)(58.6%)
rs3787268 case AA(28)(13.8%) AG(90)(44.3%) GG(74)(36.5%) 0.503 0.345 0.361
(intron 8) control AA(135)(18.5%) AG(335)(45.9%) GG(246)(33.7%)
rs2274756 case AA(6)(3%) AG(49)(24.1%) GG(137)(67.5%) 0.034* 0.020* 0.134
(exon 12) control AA(5)(0.7%) AG(147)(20.1%) GG(572)(78.4%)
Recurrent cases(n = 64)
rs3918242 case TT(2)(3%) CT(12)(18.8%) CC(43)(67.2%) 0.382 0.243 0.175
control TT(4)(0.5%) CT(125)(17.1%) CC(560)(76.7%)
rs2664538 case AA(7)(10.9%) AG(18)(28.1%) GG(36)(56.3%) 0.841 0.314 0.033*
control AA(37)(4.7%) AG(246)(33.7%) GG(428)(58.6%)
rs3787268 case AA(8)(12.5%) AG(27)(42.2%) GG(26)(40.6) 0.439 0.290 0.318
control AA(135)(18.5%) AG(335)(45.9%) GG(246)(33.7%)
rs2274756 case AA(2)(3%) AG(15)(23.4%) GG(44)(68.8%) 0.383 0.273 0.264
control AA(5)(0.7%) AG(147)(20.1%) GG(572)(78.4%)
Non-recurrent cases(n = 139)
rs3918242 case TT(4)(2.9%) CT(32)(23%) CC(94)(67.6%) 0.021* 0.014* 0.159
control TT(4)(0.5%) CT(125)(17.1%) CC(560)(76.7%)
rs2664538 case AA(9)(6.5%) AG(39)(28.1%) GG(83)(59.7%) 0.356 0.592 0.561
control AA(37)(4.7%) AG(246)(33.7%) GG(428)(58.6%)
rs3787268 case AA(20)(14.4%) AG(63)(45.3%) GG(48)(34.5%) 0.990 0.824 0.690
control AA(135)(18.5%) AG(335)(45.9%) GG(246)(33.7%)
rs2274756 case AA(4)(2.9%) AG(34)(24.5%) GG(93)(66.9%) 0.037* 0.026* 0.203
control AA(5)(0.7%) AG(147)(20.1%) GG(572)(78.4%)
Dominant, additive or recessive model: the rare allele had a dominant, additive or recessive effect
All p values were adjusted by sex and age
* p < 0.05Wang et al. BMC Medical Genetics 2010, 11:85
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models (nominal p = 0.012, empirical p = 0.011, OR =
1.60). The A allele of rs2274756 had a nominal p value of
0.034 under the dominant model and 0.020 under the
additive model. The r2  between these two significant
SNPs (rs3918242 and rs2274756) was 0.727. The exonic
SNP rs2274756 became insignificant when the regression
model also included the promoter SNP rs3918242. We
did not find any significant results for SNP rs3787268 and
rs2664538 in any of the three genetic models. In the sub-
set analysis, none of the SNPs in the recurrent patients
had a significant P value, except for the A allele of
rs2664538 under a recessive model. The p values in the
non-recurrent cases showed a similar pattern as the over-
all cases (Table 2).
LD and Haplotype Analysis
The four SNPs formed one haplotype block (Figure 1).
Haplotype analysis demonstrated a global p value of 0.015
(Table 3). The most significant haplotype TGGA
(rs3918242/rs2664538/rs3787268/rs2274756) had the
frequency of 14.7% in cases and 8.5% in controls (haplo-
type specific p value of 0.0045).
Discussion
We systematically investigated four SNPs at MMP-9 in
relation to chronic rhinosinusitis with nasal polyposis in a
Chinese population residing in Taiwan. The results
showed that three SNPs were associated with the devel-
opment of chronic rhinosinusitis with nasal polyposis.
The most significant result was from the promoter poly-
morphism of the MMP-9 gene (rs3918242, i.e. -1562 C/
T), which indicates that the rare T allele would signifi-
cantly increase the risk for nasal polyposis. We did not
find more significant results in the recurrent subjects. As
a matter of fact, the frequencies of the risk T allele at
rs3918242 and the risk A allele at rs2274756 are similar
between the non-recurrent cases and recurrent cases.
Using the haplotype analysis, the result gave us a stronger
statistical support for MMP-9 as a genetic marker. There-
fore, the current data showed that MMP-9  polymor-
phisms might influence susceptibility to the development
of chronic rhinosinusitis with nasal polyposis but might
not increase the risk for recurrence. To our knowledge,
this is the first report to demonstrate the potential contri-
bution of the MMP-9 genetic variants to the development
of chronic rhinosinusitis with nasal polyposis.
Regulation of MMPs is complex. It is considered that
regulation of MMP activity occurs at three levels: gene
transcription, activation of the secreted proenzyme and
inhibition by specific and non-specific inhibitors [18].
The regression analysis suggested that the two significant
Figure 1 LD plot of four matrix metalloproteinase-9 (MMP9) sin-
gle-nucleotide polymorphisms. The pairwise D' value (percentage) 
is displayed in each cell. The cells in dark gray indicate strong linkage 
disequilibrium. The bar on the top is the MMP9 gene structure and lo-
cation of each single-nucleotide polymorphism.
Table 3: The result from haplotype analysis which yielded a global p value of 0.015
Haplotype Patients with chronic
rhinosinusitis
Healthy controls Total p value
CGGG 23.0% 24.7% 24.4% 0.2532
CGGA 1.1% 2.2% 2.0% 0.0393
CGAG 38.1% 42.0% 40.9% 0.3813
CAGG 23.2% 22.5% 22.7% 0.7180
TGGA 14.7% 8.5% 10.1% 0.0045Wang et al. BMC Medical Genetics 2010, 11:85
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SNPs were not independent and the promoter SNP
remained significant after including the rs2274756 at
exon 12 into the model. Therefore, it is likely that the
genetic effect of MMP-9 was mainly from the promoter
SNP. Furthermore, MMP-9 protein[5-8] and mRNA[6,7]
levels were reported to be different between patients with
the chronic rhinosinusitis with nasal polyposis and con-
trols. Zhang et al. [19] also reported that the T allele of
promoter SNP rs3918242 at MMP-9 had a higher pro-
moter activity which would lead to a higher production of
MMP-9, although a recent study did not find any differ-
ential expression between the T and C alleles [20].Taken
together, the studies using different approaches consis-
tently imply that the high activity T allele is likely to
increase a risk for chronic rhinosinusitis with nasal poly-
posis.
Our study design has limitations. The sample size in the
present study was moderate, and type I error is always
possible. However, based on the result of functional SNP
rs3918242, the study population still provided a power of
85% to detect the risk allelic effect. Further studies to rep-
licate our results are necessary. The follow-up period is
limited in our study. Because nasal polyps may recur sev-
eral years after surgery, extended follow up is required
prior do drawing further conclusions. Our controls did
not receive a nasal examination to exclude the possibility
of nasal polyposis. Because the prevalence of nasal polyps
is usually less than 4% [21,22], we did not expect a signifi-
cant number of our controls to have chronic rhinosinus-
itis with nasal polyposis. Furthermore, if any controls had
chronic rhinosinusitis with nasal polyposis, the effect of
such misclassification of disease status would only
decrease the statistical power and reduce the significance.
Therefore, our conclusion is valid even though we did not
examine the controls. Although the sex distribution was
different between cases and controls, the genotype distri-
butions between male controls and female controls are
very similar. Accordingly, our results were not con-
founded by the sex effect.
Conclusions
In conclusion, our study provides novel evidence to sup-
port genetic polymorphisms in the MMP9 gene can
influence the risk for chronic rhinosinusitis with nasal
polyposis. Furthermore, the T allele of the functional pro-
moter SNP rs3918242 that has been shown to increase
MMP-9 expression is also a risk allele for chronic rhinosi-
nusitis with nasal polyposis. However, the role of MMP-9
polymorphisms in the recurrence of the disease requires
further investigation.
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